Financhill
Back

Novo Nordisk AS Stock Predictions

Novo Nordisk AS Stock Forecast

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 19.2% based on the past 43 years of stock performance.
  • Novo Nordisk AS has risen higher in 32 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 74.42%
  • Is Novo Nordisk AS Stock Undervalued?
    The current Novo Nordisk AS [NVO] share price is $88.08. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Novo Nordisk AS Stock Go Up Next Year?

  • Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 19.2% based on the past 43 years of stock performance.

Novo Nordisk AS Stock Rating

Sell
25
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS overpriced?

  • Novo Nordisk AS has risen higher in 32 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 74.42%

Novo Nordisk AS Stock Price History

Is NVO stock going to rise?

  • The current trend is relatively stagnant and NVO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com

52-Week Data

52-Week High:
148.15
52-Week Low:
77.82

Prediction Charts

Market Cap:
391B
Price in USD:
88.08
Volume:
15M
Beta:
0.49

Technical Analysis

SMA50:
88.64
SMA100:
100.12
SMA200:
117.58
52-Wk Change:
-27.16%

Stock Predictions

  • Is Novo Nordisk AS stock public?
    Yes, Novo Nordisk AS is a publicly traded company.
  • What is the Novo Nordisk AS stock quote today?
    The Novo Nordisk AS stock price is 88.08 USD today.
  • How to buy Novo Nordisk AS stock online?
    You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-3 82.13 82.65 83.38 82.07
Feb-4 81.62 82.62 83.44 81.27
Feb-5 86.43 85.73 87.42 85.09
Feb-6 86.72 87.17 88.95 86.67
Feb-7 88.69 86.42 88.77 86.14
Feb-10 85.70 83.91 85.92 83.65
Feb-11 83.55 83.74 84.25 82.87
Feb-12 81.02 81.79 82.36 80.53
Feb-13 79.62 78.83 80.14 78.70
Feb-14 78.58 77.87 79.07 77.82
Feb-18 82.10 82.33 82.68 81.06
Feb-19 82.94 83.40 83.63 82.56
Feb-20 82.93 83.74 84.00 82.71
Feb-21 88.39 88.08 89.23 85.74

Novo Nordisk AS Earnings

Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Novo Nordisk AS Forecast Revenue Growth

Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.86 per share.

* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.